Follow-on Biologics Market Report

Global and Region Follow-on Biologics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：156
  • REPORT CODE：GMM907198
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Follow-on Biologics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Follow-on Biologicsmarket, defines the market attractiveness level of Follow-on Biologics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Follow-on Biologics industry, describes the types of Follow-on Biologics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Follow-on Biologics market and the development prospects and opportunities of Follow-on Biologics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Follow-on Biologics market in Chapter 13.

    By Player:

    • Samsung Biologics

    • Biocon

    • Mylan

    • Amgen

    • Sandoz

    • Teva Pahrmaceutical

    • Stada Arzneimittel AG

    • Pfizer

    • Dr Reddy's Laboratories

    • Celltrion

    By Type:

    • Recombinant Non-glycosylated Proteins

    • Recombinant Glycosylated Proteins

    • Recombinant Peptides

    By End-User:

    • Oncology

    • Blood Disorders

    • Chronic Diseases

    • Autoimmune Diseases

    • Growth Hormone Deficiency

    • Infectious Diseases

    • Other Diseases

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Follow-on Biologics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Follow-on Biologics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Follow-on Biologics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Follow-on Biologics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Follow-on Biologics Market Analysis and Outlook to 2022

    • 7.1 Global Follow-on Biologics Consumption (2017-2022)

    • 7.2 United States Follow-on Biologics Consumption (2017-2022)

    • 7.3 Europe Follow-on Biologics Consumption (2017-2022)

    • 7.4 China Follow-on Biologics Consumption (2017-2022)

    • 7.5 Japan Follow-on Biologics Consumption (2017-2022)

    • 7.6 India Follow-on Biologics Consumption (2017-2022)

    • 7.7 South Korea Follow-on Biologics Consumption (2017-2022)

    8 Region and Country-wise Follow-on Biologics Market Analysis and Outlook to 2028

    • 8.1 Global Follow-on Biologics Consumption Forecast (2022-2028)

    • 8.2 United States Follow-on Biologics Consumption Forecast (2022-2028)

    • 8.3 Europe Follow-on Biologics Consumption Forecast (2022-2028)

    • 8.4 China Follow-on Biologics Consumption Forecast (2022-2028)

    • 8.5 Japan Follow-on Biologics Consumption Forecast (2022-2028)

    • 8.6 India Follow-on Biologics Consumption Forecast (2022-2028)

    • 8.7 South Korea Follow-on Biologics Consumption Forecast (2022-2028)

    9 Global Follow-on Biologics Market Outlook by Types and Applications to 2022

    • 9.1 Global Follow-on Biologics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Recombinant Non-glycosylated Proteins Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Recombinant Glycosylated Proteins Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Recombinant Peptides Consumption and Growth Rate (2017-2022)

    • 9.2 Global Follow-on Biologics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Growth Hormone Deficiency Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Other Diseases Consumption and Growth Rate (2017-2022)

    10 Global Follow-on Biologics Market Outlook by Types and Applications to 2028

    • 10.1 Global Follow-on Biologics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Recombinant Non-glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Recombinant Glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Follow-on Biologics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chronic Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Growth Hormone Deficiency Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)

    11 Global Follow-on Biologics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Follow-on Biologics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Follow-on Biologics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Follow-on Biologics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Follow-on Biologics Market Competitive Analysis

    • 14.1 Samsung Biologics

      • 14.1.1 Samsung Biologics Company Details

      • 14.1.2 Samsung Biologics Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Samsung Biologics Follow-on Biologics Product and Service

    • 14.2 Biocon

      • 14.2.1 Biocon Company Details

      • 14.2.2 Biocon Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Biocon Follow-on Biologics Product and Service

    • 14.3 Mylan

      • 14.3.1 Mylan Company Details

      • 14.3.2 Mylan Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mylan Follow-on Biologics Product and Service

    • 14.4 Amgen

      • 14.4.1 Amgen Company Details

      • 14.4.2 Amgen Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Follow-on Biologics Product and Service

    • 14.5 Sandoz

      • 14.5.1 Sandoz Company Details

      • 14.5.2 Sandoz Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sandoz Follow-on Biologics Product and Service

    • 14.6 Teva Pahrmaceutical

      • 14.6.1 Teva Pahrmaceutical Company Details

      • 14.6.2 Teva Pahrmaceutical Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pahrmaceutical Follow-on Biologics Product and Service

    • 14.7 Stada Arzneimittel AG

      • 14.7.1 Stada Arzneimittel AG Company Details

      • 14.7.2 Stada Arzneimittel AG Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Stada Arzneimittel AG Follow-on Biologics Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Follow-on Biologics Product and Service

    • 14.9 Dr Reddy's Laboratories

      • 14.9.1 Dr Reddy's Laboratories Company Details

      • 14.9.2 Dr Reddy's Laboratories Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Dr Reddy's Laboratories Follow-on Biologics Product and Service

    • 14.10 Celltrion

      • 14.10.1 Celltrion Company Details

      • 14.10.2 Celltrion Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Celltrion Follow-on Biologics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Follow-on Biologics

    • Figure Follow-on Biologics Picture

    • Table Global Follow-on Biologics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Follow-on Biologics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Follow-on Biologics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Follow-on Biologics Consumption by Country (2017-2022)

    • Figure United States Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table Europe Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure China Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Japan Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure India Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure United States Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Non-glycosylated Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Glycosylated Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Peptides Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormone Deficiency Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Other Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Non-glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormone Deficiency Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Follow-on Biologics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Follow-on Biologics Export by Region (Top 5 Countries) (2017-2028)

    • Table Samsung Biologics (Foundation Year, Company Profile and etc.)

    • Table Samsung Biologics Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samsung Biologics Follow-on Biologics Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Follow-on Biologics Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Follow-on Biologics Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Follow-on Biologics Product and Service

    • Table Sandoz (Foundation Year, Company Profile and etc.)

    • Table Sandoz Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Follow-on Biologics Product and Service

    • Table Teva Pahrmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pahrmaceutical Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pahrmaceutical Follow-on Biologics Product and Service

    • Table Stada Arzneimittel AG (Foundation Year, Company Profile and etc.)

    • Table Stada Arzneimittel AG Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel AG Follow-on Biologics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Follow-on Biologics Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Follow-on Biologics Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Follow-on Biologics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US